Motivation to Contribute to Share Price Appreciation and Enhanced Corporate Value through Stock Options
First written in FY2017. 7 of 11 entries say "Advanced", first in FY2018. Latest entry: FY2024-Q1.
18 other companies' latest entry also says "Other".
- FY2024-Q1The 8th Series of Share Acquisition Rights expired upon the end of its exercise periodAnnual report
「The Eighth Series Stock Acquisition Rights resolved at the Board of Directors meeting on 16 May 2018 (1,530 stock acquisition rights) lapsed on 31 May 2023 upon expiration of the exercise period.」
The 1,530 Eighth Series Stock Acquisition Rights lapsed upon expiration of the exercise period on 31 May 2023. Accordingly, a gain on reversal of stock acquisition rights of ¥45 million was recorded as extraordinary income. - FY2023Partial lapse of the Eighth Series Stock Acquisition RightsAnnual report
「Lapsed － 6,500 －」
As a change in stock options during the year, the lapse of 6,500 shares underlying the Eighth Series Stock Acquisition Rights has been recorded. The number of unexercised rights at fiscal year-end was 7,600 shares for the Seventh Series, 153,000 shares for the Eighth Series and 17,600 shares for the Ninth Series. - FY2023-Q1AdvancedAnnual report
「During the first quarter accounting period, 12,600 shares underlying share acquisition rights were exercised. As a result, treasury shares totaled 2,261,654 shares at the end of the first quarter accounting period, representing 9.20% of total issued shares.」
The exercise of 12,600 shares underlying stock acquisition rights during the first quarter has been recorded, providing an additional record of the implementation of the stock option program. - FY2022AdvancedAnnual report
「Exercise 3,800 － 8,800」
During the year, 3,800 shares underlying the Seventh Series Stock Acquisition Rights and 8,800 shares underlying the Ninth Series Stock Acquisition Rights were exercised. The stock option program continues to be implemented. - FY2022-Q1AdvancedAnnual report
「During the first quarter accounting period, 12,600 shares underlying share acquisition rights were exercised. As a result, treasury shares totaled 2,261,654 shares at the end of the first quarter accounting period, representing 9.20% of total issued shares.」
During the first quarter, 12,600 shares underlying stock acquisition rights were exercised, providing additional confirmation of the implementation of the stock option program. - FY2021AdvancedAnnual report
「The purpose is for the company's directors other than outside directors to share the benefits and risks of share-price fluctuations with shareholders and further strengthen their incentive to contribute to higher share prices and corporate value.」
At a meeting of the Board of Directors held on 25 March 2021, the company resolved to grant 352 stock options, covering 35,200 shares, to 4 directors other than outside directors. - FY2021-Q3AdvancedAnnual report
「During the third quarter accounting period, the company purchased 30 odd-lot shares and 1,000 shares underlying share acquisition rights were exercised. As a result, treasury shares totaled 2,274,254 shares at the end of the third quarter accounting period, representing 9.25% of total issued shares.」
During the third quarter accounting period, 1,000 shares underlying share acquisition rights were exercised, providing an additional confirmation of the implementation of the stock option program. - FY2020AdvancedAnnual report
「Exercise: 3,800」
A total of 3,800 shares underlying the 7th Series of Share Acquisition Rights were exercised, leaving 15,200 shares unexercised. This shows the implementation of the stock option program. - FY2019RestatedAnnual report
「At the 50th Annual General Meeting of Shareholders held on 13 June 2017, the company resolved to establish, separately from the compensation amount for the directors described above, an annual limit of ¥80 million for compensation related to share acquisition rights as stock options for directors other than outside directors, after abolishing the previous compensation framework. The purpose was to ensure that these directors continued to share the benefits and risks of share-price fluctuations with shareholders and to further strengthen their incentive to contribute to higher share prices and corporate value.」
We continue to maintain an annual stock option compensation limit of ¥80 million for directors and the policy of strengthening alignment with shareholders and the incentive to contribute to higher corporate value. - FY2018AdvancedAnnual report
「At a meeting of the Board of Directors held on 16 May 2018, the company resolved, pursuant to Articles 236, 238 and 239 of the Companies Act, to issue share acquisition rights to the company's directors other than outside directors and its employees.」
The company resolved to issue 190 share acquisition rights (19,000 shares) to 5 directors and 4,485 share acquisition rights (448,500 shares) to 371 employees, specifying the stock option program. - FY2017First statedAnnual report
「At the 50th Annual General Meeting of Shareholders held on 13 June 2017, the company resolved to establish, separately from the compensation amount for the directors described above, an annual limit of ¥80 million for compensation related to share acquisition rights as stock options for directors other than outside directors, after abolishing the previous compensation framework. The purpose was to ensure that these directors continued to share the benefits and risks of share-price fluctuations with shareholders and to strengthen their incentive to contribute to higher share prices and corporate value.」
A resolution established an annual limit of ¥80 million for stock option compensation for directors and introduced a mechanism to align their interests with shareholders and strengthen their incentive to contribute to higher share prices and corporate value. The resolution also set an upper limit of 500,000 shares underlying share acquisition rights for employees.